01652 福森藥業
按盘价 
0.290 0.000 (0.000%) 盈利能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 资产回报率 (%) | -14.624% | -2.693% | -2.673% | 1.342% | 5.802% |
| 股东资金回报率 (%) | -40.460% | -6.161% | -5.440% | 2.527% | 10.523% |
| 资本运用回报率 (%) | -40.536% | -5.341% | -5.509% | 2.219% | 10.109% |
边际利润分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 毛利率 (%) | 49.884% | 52.953% | 45.759% | 54.745% | 54.650% |
| 未计利息、税项、折旧及摊销前利润率 (%) | -7.913% | 6.274% | 8.116% | 14.687% | 17.323% |
| 税前边际利润率 (%) | -58.414% | -5.206% | -6.303% | 6.169% | 16.104% |
| 纯利率 (%) | -57.904% | -6.414% | -7.037% | 4.316% | 14.405% |
变现能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 流动比率 (X) | 0.595 X | 0.853 X | 0.850 X | 1.041 X | 1.206 X |
| 速动比率 (X) | 0.418 X | 0.610 X | 0.697 X | 0.792 X | 1.013 X |
财务杠杆分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 总负债 / 总资产比率 (%) | 70.249% | 58.160% | 54.610% | 46.992% | 46.973% |
| 总债项 / 总资产比率 (%) | 30.989% | 25.609% | 16.914% | 19.421% | 15.991% |
| 净债项 / 总资产比率 (%) | 29.288% | 23.015% | 7.426% | 12.880% | -7.938% |
| 总债项 / 股东资金比率 (%) | 103.793% | 61.065% | 37.185% | 36.569% | 30.101% |
| 长期债项 / 股东资金比率 (%) | 21.433% | 18.894% | 0.070% | 11.842% | 3.033% |
| 净债项 / 股东资金比率 (%) | 98.097% | 54.881% | 16.327% | 24.253% | -14.943% |
| 净现金 / (债项) ($) | (3.63亿) | (3.09亿) | (1.00亿) | (1.60亿) | 9.85千万 |
| 每股净现金 / (债项) ($) | (0.491) | (0.412) | (0.132) | (0.207) | 0.127 |
| 总债项 / 资本运用比率 (%) | 82.388% | 50.663% | 36.356% | 32.089% | 28.613% |
| 利息盈利率 (X) | N/A | N/A | N/A | 3.886 X | 9.311 X |
营运效率分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 存货周转率日数 (日) | 333.743日 | 186.797日 | 159.072日 | 237.637日 | 160.209日 |
| 应收贸易帐周转率日数 (日) | 166.452日 | 138.961日 | 150.218日 | 161.606日 | 132.734日 |
| 应付贸易帐周转率日数 (日) | 162.898日 | 106.852日 | 98.617日 | 99.705日 | 66.531日 |
| 备注： | 实时报价更新时间为16/05/2025 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -188,783,000 |
| 增长率 | 420.393% |
| 每股盈利/(亏损) | RMB -0.260 |
| 每股账面资产净值 (¥) | RMB 0.500 |